
Stroke trial presentations accepted for prestigious international conference
Argenica Therapeutics, the WA based biotechnology company developing novel therapeutics to reduce brain tissue death after stroke and other acute...
Continue reading
This website may not work correctly in Internet Explorer. We recommend switching to a more secure modern web browser such as Microsoft Edge which is already installed on your computer.
Research groups
Dr May Aung-Htut is the Co-Head of the Molecular Therapy Laboratory at the Personalised Medicine Centre and Co Leads the UltRare Research Group.
Dr Aung-Htut graduated with a PhD in Biochemistry and Molecular Genetics from the University of New South Wales (UNSW). Her current research focuses on designing and evaluating therapeutic antisense oligonucleotides for to treat both rare genetic disorders and common diseases such as cardiovascular diseases. Currently, Dr Aung-Htut and colleagues are driving towards innovative precision therapies for children with rare diseases, specifically n-of-1 approaches.
Keep informed with our latest updates.
Stay up to date with our latest news and announcements.